Gouws Capital LLC Lowers Stock Position in Amgen Inc. $AMGN

Gouws Capital LLC significantly reduced its stake in Amgen Inc. by 41.9% in the fourth quarter, selling 5,610 shares and now holding 7,795 shares valued at $2.55 million. Despite this, Amgen exceeded Q1 earnings estimates with $5.15 EPS and $8.62 billion in revenue, showing strong product sales growth. Analyst sentiment remains mixed, with some raising price targets but the overall consensus rating being a “Hold” due to regulatory concerns and strategic uncertainties.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin